Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - TOTAL LIABILITIES
Total Liabilities ANVS - Annovis Bio, Inc.
18 M
LAST VALUE
245.27%
2 YEAR CAGR
18.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR